기관지경 : 시장 인사이트, 경쟁 환경, 시장 예측(-2030년)

Bronchoscope by Product Type (Rigid Bronchoscopes, Flexible Fiber Bronchoscopes, Flexible Video Bronchoscopes, and Mobile Bronchoscopes), Flexibility (Flexible and Rigid), Usability (Single-Use and Reusable), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of chronic respiratory diseases, growing risk factors leading to respiratory disorders, and increase in product launches and approvals by key market players across the globe.

The global bronchoscopes market was valued at USD 17.89 billion in 2023, growing at a CAGR of 7.43% during the forecast period from 2024 to 2030 to reach USD 27.48 billion by 2030. The overall market for bronchoscopes is significantly boosted by several interrelated factors. The rising burden of chronic respiratory diseases creates a growing demand for advanced diagnostic and therapeutic tools, including bronchoscopes, to manage and treat these conditions effectively. Further, the surge in cigarette smoking further exacerbates respiratory issues, increasing the need for bronchoscope evaluations and interventions. Additionally, heightened awareness and the implementation of screening programs for early detection of respiratory diseases drive more individuals to seek bronchoscope procedures, contributing to market growth. Furthermore, the continuous increase in product launches and approvals by key market players across the globe introduces innovative bronchoscope technologies, enhancing their capabilities and broadening their applications thereby escalating the overall market during the forecast period from 2024 to 2030.

Bronchoscope Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffers from chronic respiratory diseases.

Furthermore, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people had COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases.

Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, are driving significant growth in the bronchoscope market. As these conditions become increasingly prevalent, the demand for diagnostic and therapeutic tools to manage and monitor respiratory health is rising. Bronchoscopes are crucial for visualizing the airways, diagnosing disease progression, and guiding treatment interventions. The increasing incidence of chronic respiratory diseases has led to greater utilization of bronchoscopes in clinical practice, boosting market expansion.

Additionally, as per the recent data provided by GLOBOCAN, in 2022, globally the estimated new cases of trachea, bronchus, and lung cancer was 2.48 million, and the projections are expected to rise 4.25 million by the year 2045. As the incidence of lung cancer rises, there is an increased demand for advanced diagnostic tools to detect tumors early and accurately. Bronchoscopes are essential for performing bronchoscopy procedures, which allow clinicians to visualize the interior of the lungs, obtain tissue samples for biopsy, and guide targeted therapies. Enhanced bronchoscopy technologies, such as endobronchial ultrasound (EBUS) and narrow-band imaging (NBI), offer improved diagnostic capabilities, which are vital for early lung cancer detection and staging. As more patients seek timely and precise diagnosis and treatment, the growing need for sophisticated bronchoscope tools drives market expansion and innovation in this sector.

Thus, the factors mentioned above are likely to boost the market of bronchoscope during the forecasted period.

However, bronchoscopy-related procedural complications and risk of infection associated with reusable bronchoscopes may hinder the future market of bronchoscope.

Bronchoscope Market Segment Analysis:

Bronchoscope by Product Type (Rigid Bronchoscopes, Flexible Fiber Bronchoscopes, Flexible Video Bronchoscopes, and Mobile Bronchoscopes), Flexibility (Flexible and Rigid), Usability (Single-Use and Reusable), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of bronchoscope market the flexible fiber bronchoscopes are expected to hold a significant share in 2023. Flexible fiber bronchoscopes are significantly boosting the overall market of bronchoscopes due to their enhanced capabilities and advantages over traditional rigid bronchoscopes. Flexible fiber bronchoscopes offer superior maneuverability compared to rigid bronchoscopes. Their flexibility allows them to navigate through the complex anatomy of the airways and reach distal areas of the lungs more easily. This capability is crucial for accurate diagnosis and effective treatment of conditions in hard-to-reach regions, making them more desirable in clinical settings. The flexible nature of these bronchoscopes enables minimally invasive procedures, which generally result in less patient discomfort, reduced recovery time, and fewer complications. Patients are more likely to undergo bronchoscopy when the procedure is less invasive, contributing to increased utilization and market demand. Flexible fiber bronchoscopes often come equipped with advanced imaging technologies, such as high-definition cameras and light sources. These features enhance the visualization of airway structures and abnormalities, leading to more accurate diagnoses of conditions like lung cancer, infections, and chronic respiratory diseases.

Furthermore, continuous advancements in flexible fiber bronchoscope technology, such as improvements in image quality, miniaturization, and ease of use, contribute to their growing popularity. Innovations such as digital imaging and integration with other diagnostic tools enhance their functionality and appeal, driving market growth. For instance, in November 2023, Johnson & Johnson MedTech announced that the MONARCH Platform and MONARCH Bronchoscope received regulatory approval in China.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global bronchoscope market during the forecast period.

North America is expected to dominate the overall bronchoscope market:

North America is expected to account for the highest proportion of the bronchoscope market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease and lung cancer across the region, increase in technological advancement, increase government initiatives coupled with increased awareness programs for respiratory disorders, and the presence of key market players engaged in merges, acquisition, product launches, and other market activities across the region are expected to escalate the market of bronchoscope during the forecast period.

According to the recent data and stats provided by American Lung Association (2024), in 2022, among children the asthma was more common in males accounting 7.0% of the population in the United States and 5.4% in females.

Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties. Accurate diagnosis and management are crucial, and bronchoscopes play a vital role in assessing airway inflammation, monitoring disease progression, and identifying triggers. As the prevalence of asthma continues to rise globally, the demand for bronchoscope evaluations to better understand and manage the condition increases.

Furthermore, as per the recent data and stats provided by Centre for Disease Control and Prevention (2023), in 2021, approximately 11.5% of U.S. adults aged 18 and older smoked cigarettes, totaling around 28.3 million smokers. At that time, over 16 million Americans were living with a smoking-related disease. Smokers are at a significantly higher risk of developing lung cancer. Early detection is crucial for improving outcomes, and bronchoscopes play a vital role in identifying lung tumors, obtaining biopsies, and staging the disease. Thus, the increased need for lung cancer screening in smokers drives demand for advanced bronchoscope technologies.

Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the bronchoscope market. For instance, in June 2021, Ambu Inc. received the product approval from the US Food and Drug Administration for their single-use bronchoscope and sample collection system. The product launched in the local markets correlated to a significant reduction in costs thereby making them affordable for end users which in turn drives the product demand in the market.

Therefore, the above-mentioned factors are expected to bolster the growth of the bronchoscope market in the North America during the forecast period.

Bronchoscope Market Key Players:

Some of the key market players operating in the Bronchoscope market include Boston Scientific Corporation, Ambu Inc, Olympus, Richard Wolf GmbH, Karl Storz, FUJIFILM Corporation, PENTAX Medical (HOYA Corporation), Teleflex Incorporated, Innovex Medical Co., Ltd, Zhuhai Seesheen Medical Technology Co.,Ltd, EMOS Technology GmbH, Optomic., Clarus Medical LLC, The Surgical Company., Hunan Vathin Medical Instrument Co., Ltd., Aohua Endoscopy Co., Ltd, Verathon, Inc., Lymol Medical, Novatech SA, NeoScope Inc., and others.

Recent Developmental Activities in the Bronchoscope Market:

• In May 2024, Olympus, a global medical technology company, announced the launch of two bronchoscopes as part of the EVIS X1 Endoscopy System. The EVIS X1 Endoscopy System represented the latest advancements in diagnostic and therapeutic bronchoscopy from Olympus.
• In April 2024, Moffitt launched a new robotic bronchoscopy platform that utilized fiber optics and the smallest catheter on the market to reach all areas of the lung.
• In August 2021, Boston Scientific Corporation received the product approval from the US Food and Drug Administration for their EXALT Model B Single-Use Bronchoscope.

Key Takeaways From the Bronchoscope Market Report Study:

• Market size analysis for current bronchoscope size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the bronchoscope market.
• Various opportunities available for the other competitors in the bronchoscope market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current bronchoscope market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bronchoscope market growth in the coming future?

Target Audience who can be Benefited From This Bronchoscope Market Report Study:

• Bronchoscope product providers
• Research organizations and consulting companies
• Bronchoscope -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in bronchoscope
• Various end-users who want to know more about the bronchoscope market and the latest technological developments in the bronchoscope market.

Frequently Asked Questions for the Bronchoscope Market:

1. What are bronchoscope?

• A bronchoscope is a medical instrument used to examine the airways and lungs. It is a thin, flexible tube equipped with a light and a camera, allowing healthcare providers to visualize the inside of the trachea, bronchi, and bronchioles.

2. What is the market for bronchoscope?

• The global bronchoscopes market was valued at USD 17.89 billion in 2023, growing at a CAGR of 7.43% during the forecast period from 2024 to 2030 to reach USD 27.48 billion by 2030.

3. What are the drivers for the bronchoscope market?

• The overall market for bronchoscopes is significantly boosted by several interrelated factors. The rising burden of chronic respiratory diseases. Additionally, heightened awareness and the implementation of screening programs for early detection of respiratory diseases drive more individuals to seek bronchoscope procedures, contributing to market growth. Furthermore, the continuous increase in product launches and approvals by key market players across the globe introduces innovative bronchoscope technologies, enhancing their capabilities and broadening their applications thereby escalating the overall market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the bronchoscope market?

• Some of the key market players operating in the bronchoscope market include Boston Scientific Corporation, Ambu Inc, Olympus, Richard Wolf GmbH, Karl Storz, FUJIFILM Corporation, PENTAX Medical (HOYA Corporation), Teleflex Incorporated, Innovex Medical Co., Ltd, Zhuhai Seesheen Medical Technology Co.,Ltd, EMOS Technology GmbH, Optomic., Clarus Medical LLC, The Surgical Company., Hunan Vathin Medical Instrument Co., Ltd., Aohua Endoscopy Co., Ltd, Verathon, Inc., Lymol Medical, Novatech SA, NeoScope Inc., and others.

5. Which region has the highest share in the bronchoscope market?

• North America is expected to account for the highest proportion of the bronchoscope market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease and lung cancer across the region, increase in technological advancement, increase government initiatives coupled with increased awareness programs for respiratory disorders, and the presence of key market players engaged in merges, acquisition, product launches, and other market activities across the region are expected to escalate the market of bronchoscope during the forecast period.

Table of Contents

1. Bronchoscope Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Bronchoscope Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Bronchoscope Market Key Factors Analysis

• 5.1. Bronchoscope Market Drivers
  • 5.1.1. Rising burden of chronic respiratory diseases
  • 5.1.2. Increasing risk factors associated with respiratory disorders
  • 5.1.3. Growing product launches and approvals by key market players across the globe
• 5.2. Bronchoscope Market Restraints and Challenges
  • 5.2.1. Bronchoscopy-related procedural complications
  • 5.2.2. Risk of infection associated with reusable bronchoscopes
• 5.3. Bronchoscope Market Opportunities
  • 5.3.1. Ongoing innovations in bronchoscopy, such as the ultra-thin, flexible bronchoscopes, robotic-assisted systems, and advanced imaging techniques (like 3D imaging)

6. Bronchoscope Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Bronchoscope Market Assessment

• 7.1. By Product Type
  • 7.1.1. Rigid Bronchoscopes
  • 7.1.2. Flexible Fiber Bronchoscopes
  • 7.1.3. Flexible Video Bronchoscopes
  • 7.1.4. Mobile Bronchoscopes
• 7.2. By Flexibility
  • 7.2.1. Flexible Bronchoscopes
  • 7.2.2. Rigid Bronchoscopes
• 7.3. By Usability
  • 7.3.1. Single-Use Bronchoscopes
  • 7.3.2. Reusable Bronchoscopes
• 7.4. By End-User
  • 7.4.1. Hospitals
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.1.2. Canada Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.1.3. Mexico Bronchoscope Market Size in USD Million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.2.2. Germany Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.2.3. United Kingdom Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.2.4. Italy Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.2.5. Spain Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.2.6. Rest of Europe Bronchoscope Market Size in USD Million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.3.2. Japan Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.3.3. India Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.3.4. Australia Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.3.5. South Korea Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Bronchoscope Market Size in USD Million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.4.2. Africa Bronchoscope Market Size in USD Million (2021-2030)
    • 7.5.4.3. South America Bronchoscope Market Size in USD Million (2021-2030)

8. Bronchoscope Market Company and Product Profiles

• 8.1. Boston Scientific Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Ambu Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Olympus
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Richard Wolf GmbH
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Karl Storz
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. FUJIFILM Corporation
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. PENTAX Medical (HOYA Corporation)
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Teleflex Incorporated
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Innovex Medical Co., Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Zhuhai Seesheen Medical Technology Co.,Ltd.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. EMOS Technology GmbH
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Optomic.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Clarus Medical LLC
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. The Surgical Company.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Hunan Vathin Medical Instrument Co., Ltd.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Aohua Endoscopy Co., Ltd.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Verathon, Inc.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Lymol Medical
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Novatech SA
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. NeoScope Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us